Is a complete SMTI research report available?

No complete published report is available for Sanara MedTech Inc. (SMTI) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Sanara MedTech Inc. (SMTI)

NASDAQ: SMTI · USD

$34.1

+3.81 (+12.6%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first SMTI analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	312.1M
Revenue (ttm)	107.5M
Net income (ttm)	-33.6M
EPS (ttm)	-$3.89
Shares out	9.2M
P/E (forward)	137.6x
Volume	3,274,065
Beta	1.18
Price target	$34.0

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All SMTI indicators

Market & fundamental data

Available fields

239

Groups with data

Currency

USD

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000714256
Company name	Sanara MedTech Inc.
Country	United States
Country code	US
Cusip	79957L100
Employees	108
Employees Change	-33%
Employees Change Percent	-23.4
Enterprise value	$346.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Instruments & Supplies
Industry PE	68.75
Industry PE Fwd	21.82
Isin	US79957L1008
Last refreshed	2026-07-31
Market cap	$312.1M
Market cap category	Micro-Cap
Price	$34.06
Price currency	USD
Rev Per Employee	995,207.59x
Sector	Healthcare
Sector PE	45.51
Sector PE Fwd	24.23
Sic	3842
Symbol	SMTI
Website	https://sanaramedtech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-10.76%
EV Sales Forward	3.84x
EV/EBIT	52.5x
EV/EBITDA	34.64x
EV/FCF	102.83x
EV/Sales	3.23x
FCF yield	1.08%
Forward P/E	137.62x
P/B ratio	44.41x
P/S ratio	2.9x
PS Forward	3.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.15%
EBITDA Margin	9.32%
FCF margin	3.14%
Gross margin	92.92%
Gross Profit	$99.9M
Gross Profit Growth	19.63%
Gross Profit Growth Q	19.8%
Gross Profit Growth3 Y	29.61%
Gross Profit Growth5 Y	45.51%
Net Income	$-33.6M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	0.58%
Profit Margin	-31.24%
Profit Per Employee	$-310,893
Profitable Quarters	$1
ROA	8.28
Roa5y	-6.81
ROCE	11.89
ROE	2.86
Roe5y	-16.72
ROIC	10.02

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	18.97%
Cagr15y	-2.53%
Cagr1y	36.16%
Cagr20y	6.32%
Cagr3y	-5.88%
Cagr5y	-3.97%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	17.38x
Revenue Growth Q	18.62x
Revenue Growth Quarters	23x
Revenue Growth Years	7x
Revenue Growth3 Y	26.14x
Revenue Growth5 Y	44.48x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.3
Assets	$69.3M
Cash	$13.6M
Current Assets	$31.2M
Current Liabilities	$13.7M
Debt	$48.4M
Debt EBITDA	$4.83
Debt Equity	$6.89
Debt FCF	$14.34
Equity	$7M
Interest Coverage	0.91
Liabilities	$62.3M
Long Term Assets	$38.1M
Long Term Liabilities	$48.6M
Net Cash	$-34.8M
Net Cash By Market Cap	$-11.14
Net Debt EBITDA	$3.47
Net Debt Equity	$4.95
Net Debt FCF	$10.31
Tangible Book Value	$-14.4M
Tangible Book Value Per Share	$-1.57
WACC	10.87

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.28
Inventory Turnover	2.42
Net Working Capital	$4.3M
Quick ratio	1.99
Working Capital	$17.5M
Working Capital Turnover	$5.24

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.59%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	467.67%
1Y total return	36.13%
200-day SMA	22.4
3Y total return	-16.62%
50-day SMA	23.84
50-day SMA vs 200-day SMA	50over200
5Y total return	-18.32%
All Time High	7,800
All Time High Change	-99.56%
All Time High Date	1997-08-19
All Time Low	0.9
All Time Low Change	3,684.44%
All Time Low Date	2002-06-26
ATR	1.67
Beta	1.18
Beta1y	1.69
Beta2y	1.38
Ch YTD	45.87
High	34.25
High52	35.95
High52 Date	2025-09-08
High52ch	-5.26%
Low	33.35
Low52	16.05
Low52 Date	2026-03-25
Low52ch	112.25%
Ma50ch	42.9%
Premarket Change Percent	10.61
Premarket Price	$33.46
Premarket Volume	50,199
Price vs 200-day SMA	52.07%
RSI	84.37
RSI Monthly	56.64
RSI Weekly	72.23
Sharpe ratio	0.74x
Sortino ratio	1.23
Total Return	-1.59%
Tr YTD	45.87
Tr15y	-31.88%
Tr1m	38.57%
Tr1w	33.57%
Tr3m	87.14%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	0
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.05
Earnings Revenue Estimate	28,650,000x
Earnings Revenue Estimate Growth	10.91x
Operating Income	$11M
Operating Income Growth	162.7
Operating Income Growth Q	220.6
Operating margin	10.2
Price target	$34
Price Target Change	$-0.18

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,737,363%
Float Percent	40.78%
Shares Insiders	31.41%
Shares Institutions	16.53%
Shares Out	9,163,969
Shares Qo Q	6.05%
Shares Yo Y	1.59%
Short Float	10.1%
Short Ratio	5.71
Short Shares	4.12

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-1.3M
Adjusted OCF	1,650,571
Average Volume	240,368.6x
Bv Per Share	0.77
CAPEX	$-2.9M
Ch10y	467.7
Ch15y	-31.88
Ch1m	38.57
Ch1w	33.57
Ch1y	36.13
Ch20y	240.6
Ch3m	87.14
Ch3y	-16.62
Ch5y	-18.32
Ch6m	61.73
Change	12.6%
Change From Open	1.76
Close	30.25
Days Gap	10.64
Depreciation Amortization	2,555,093
Dollar Volume	111,514,653.9
Earnings Date	2026-08-10
Earnings Time	bmo
EBIT	$6.6M
EBITDA	$10M
EPS	$-3.89
F Score	5
FCF	$3.4M
FCF EV Yield	0.97x
FCF Per Share	$0.37
Financing CF	-3,575,646
Fiscal Year End	December
Founded	1,982
Goodwill	3,601,781
Investing CF	-9,837,807
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-11
Last Report Date	2026-03-31
Last Split Date	2019-05-10
Last Split Type	Reverse
Last10k Filing Date	2026-03-24
Ma150	21.47
Ma150ch	58.66%
Ma20	25.69
Ma20ch	32.57%
Net CF	-7,093,347
Next Earnings Date	2026-08-12
Open	33.47
Optionable	No
P FCF Ratio	92.53
P OCF Ratio	49.39
P OCF Ratio SBC	189.1
Position In Range	78.89
Post Close	34.06
Postmarket Change Percent	-0.53
Postmarket Price	$33.88
Ppne	2,452,730
Pre Close	30.25
Price Date	2026-07-30
Price EBITDA	$31.16
Relative Volume	13.93x
Revenue	107,482,420x
SBC By Revenue	4.34x
Share Based Comp	4,669,535
Tr20y	240.6%
Tr6m	61.73%
Us State	Texas
Volume	3,274,065
Z Score	3.16

Sanara MedTech Inc. (SMTI)

Coverage state: Market snapshot only — no published research

Generate the first SMTI analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · SMTI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SMTI indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on SMTI

Frequently asked questions